CTLA4Ig Improves Murine iTreg Induction via TGFβ and Suppressor Function In Vitro
Blockade of the CD28:CD80/86 costimulatory pathway has been shown to be potent in blocking T cell activation in vitro and in vivo. The costimulation blocker CTLA4Ig has been approved for the treatment of autoimmune diseases and transplant rejection. The therapeutic application of regulatory T cells...
Saved in:
| Main Authors: | Nina Pilat, Benedikt Mahr, Martina Gattringer, Ulrike Baranyi, Thomas Wekerle |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2018/2484825 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapamycin Regulates iTreg Function through CD39 and Runx1 Pathways
by: Yunjie Lu, et al.
Published: (2014-01-01) -
IL-2/α-IL-2 Complex Treatment Cannot Be Substituted for the Adoptive Transfer of Regulatory T cells to Promote Bone Marrow Engraftment.
by: Benedikt Mahr, et al.
Published: (2016-01-01) -
CTLA-4 expression on tregs is needed for suppression of autoimmune uveitis
by: Minjun Ahn, et al.
Published: (2025-05-01) -
Th17/Treg balance is regulated by myeloid‐derived suppressor cells in experimental autoimmune myocarditis
by: Xin Xiong, et al.
Published: (2023-06-01) -
The TGF-β Family: Signaling Pathways, Developmental Roles, and Tumor Suppressor Activities
by: Aaron N. Johnson, et al.
Published: (2002-01-01)